Bromocriptine in anorexia nervosa. 1978

A D Harrower

UI MeSH Term Description Entries
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000856 Anorexia Nervosa An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. (APA, Thesaurus of Psychological Index Terms, 1994) Anorexia Nervosas,Nervosa, Anorexia,Nervosas, Anorexia

Related Publications

A D Harrower
October 1977, La Nouvelle presse medicale,
A D Harrower
April 2017, Current problems in pediatric and adolescent health care,
A D Harrower
October 1971, British medical journal,
A D Harrower
November 2003, MMW Fortschritte der Medizin,
A D Harrower
November 1982, The Practitioner,
A D Harrower
February 1963, Naika. Internal medicine,
A D Harrower
November 1982, American family physician,
A D Harrower
November 1996, Journal of the Indian Medical Association,
A D Harrower
August 1983, Midwife, health visitor & community nurse,
A D Harrower
November 1963, Postgraduate medicine,
Copied contents to your clipboard!